Pathstone Family Office’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $454K | Buy |
6,221
+3,099
| +99% | +$226K | ﹤0.01% | 1081 |
|
|
2023
Q2 | $260K | Sell |
3,122
-679
| -18% | -$56.5K | ﹤0.01% | 1030 |
|
|
2023
Q1 | $290K | Sell |
3,801
-20,345
| -84% | -$1.55M | ﹤0.01% | 924 |
|
|
2022
Q4 | $976K | Buy |
24,146
+13,486
| +127% | +$545K | 0.01% | 801 |
|
|
2022
Q3 | $845K | Buy |
10,660
+7,643
| +253% | +$606K | 0.01% | 827 |
|
|
2022
Q2 | $224K | Buy |
+3,017
| New | +$224K | ﹤0.01% | 912 |
|
|
2019
Q2 | – | Sell |
-1,140
| Closed | -$103K | – | 914 |
|
|
2019
Q1 | $103K | Buy |
+1,140
| New | +$103K | 0.01% | 229 |
|